Tech Company Financing Transactions
Vaxess Technologies Funding Round
On 11/2/2022, Vaxess Technologies raised $27 million in Series B funding from RA Capital and private investors.
Transaction Overview
Company Name
Announced On
11/2/2022
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series B
Investors
RA Capital (Lead Investor) (Mario Barro)
Proceeds Purpose
The money helped the company finally begin the first clinical trial of its technology in August.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Boston, MA 02134
USA
Phone
Website
Email Address
Overview
Our mission is to increase global vaccine access while lowering the cost of distribution.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Schrader
Chief Technical Officer
Mark Tracy
Co-Founder
Fiorenzo Omenetto
VP - Bus. Development
Livio Valenti
VP - R & D
Jonathan Kluge
VP - R & D
Kathryn Kosuda
Browse more venture capital transactions:
Prev: 11/2/2022: Volta Greentech venture capital transaction
Next: 11/2/2022: Carta Healthcare venture capital transaction
Share this article
About Our VC Transactions Data
We document funding rounds that are announced publicly. VC investment data records on this site come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs